MSH AND NOVO NORDISK: A CALL TO ACTION AT THE WORLD HEALTH ASSEMBLY

Photo Credit: Rui Pires

Photo Credit: Rui Pires

As a call to action to put gestational diabetes on the global development agenda, MSH and Novo Nordisk sponsored a technical advocacy event at the 68th World Health Assembly in Geneva. Moderated by Dr. Jonathan D. Quick, President and CEO of MSH, the event examined the growing burden of gestational diabetes and showcased solutions and lessons learned from Ethiopia, Colombia, and Nigeria.